ORS § 689.NEW

Current through 2024 Regular Session legislation effective April 17, 2024
Section 689.NEW - [Newly enacted section not yet numbered]
(1) As used in this section:
(a) "Early refill" means:
(A) Up to three refills of a current prescription for a medication that a patient has lost or that has been stolen or destroyed; or
(B) One refill in a 12 month period of a medication for which the previous prescription expired in the prior 12 month period.
(b) "Refill" means a supply of a medication consistent with the amount specified in the most recent prescription for the medication.
(2) A pharmacist may prescribe and dispense to a patient, to the extent permitted by federal law, an early refill of a medication for the treatment of opioid use disorder in accordance with subsection (3) of the section.
(3) A pharmacist who prescribes and dispenses early refills under this section shall:
(a) Complete a patient assessment to determine whether the prescription is appropriate;
(b) Document the patient visit and include notations regarding evidence of the patient's previous prescription from the patient's licensed health care provider, information relating to the patient's treatment and other relevant information; and
(c) Notify the patient's primary care provider, and the licensed health care provider who made the previous prescription, of the pharmacist's dispensing of early refills, to the extent permitted by state and federal law.
(4) Notations in a record documenting evidence of a patient's previous prescription under subsection (3)(b) of this section constitute verification of a valid prescription.
(5) The State Board of Pharmacy shall adopt rules to carry out this section, including but not limited to rules to allow a:
(a) Pharmacist to apply for and obtain a registration number from the Drug Enforcement Administration of the United States Department of Justice as a mid-level practitioner; and
(b) Pharmacy to store on the premises medications for the treatment of opioid use disorder.
(6) In adopting rules to carry out this section, the board shall consult with the Public Health and Pharmacy Advisory Formulary Committee described in ORS 689.649.

ORS 689.NEW

Added by 2024 Ch. 70,§ 7, eff. 4/1/2024.